Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2874180 | 0.93 | ALDH1A1 (1.00) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL9000687 | 0.91 | ALDH1A1 (0.74) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL1581464 | 0.87 | ALDH1A1 (0.68) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL5031039 | 0.85 | ALDH1A1 (0.65) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL824471 | 0.85 | ALDH1A1 (0.66) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL8229602 | 0.85 | ALDH1A1 (0.66) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL20707338 | 0.83 | ALDH1A1 (0.63) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL6270890 | 0.83 | ALDH1A1 (0.63) | ALDH1A1KMT2AHPGDMAPTSMN1; SMN2 | |
| SCHEMBL6683314 | 0.83 | ALDH1A1 (0.63) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 | |
| SCHEMBL10886619 | 0.82 | KMT2A (0.64) | ALDH1A1KMT2AHPGDCYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4988662-A | MULTILAYER ELEMENT OF A COATED SUBSTRATE, A FILM WITH A COLOR-FORMING LACTONE, AN ACID AND A SENSITIZER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-01-29 | — | — | US | claimed |
| JP-2029382-A | — | — | None | — | — | JP | disclosed |
| US-20240049386-A1 | LAMINATE AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2024-02-08 | — | — | US | disclosed |
| CN-117465091-A | Laminate and electronic device | 富士胶片株式会社 | 2024-01-30 | — | — | CN | disclosed |
| EP-3438752-B1 | POSITIVELY CHARGEABLE ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE FORMING APPARATUS | MITSUBISHI CHEM CORP (JP) | 2022-01-12 | — | — | EP | disclosed |
| CN-106892968-B | Synthesis method of linaclotide | 深圳翰宇药业股份有限公司 | 2021-11-05 | — | — | CN | disclosed |
| CN-108348402-B | Polymerizable composition based on thermally cleavable compounds | 义获嘉伟瓦登特公司 | 2021-02-02 | — | — | CN | disclosed |
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | IVOCLAR VIVADENT AG (LI) | 2020-06-02 | — | — | US | disclosed |
| EP-3156031-B9 | POLYMERISABLE COMPOSITIONS BASED ON THERMALLY CLEAVABLE COMPOUNDS | IVOCLAR VIVADENT AG (LI) | 2020-03-18 | — | — | EP | disclosed |
| EP-3156031-B1 | POLYMERISABLE COMPOSITIONS BASED ON THERMALLY CLEAVABLE COMPOUNDS | IVOCLAR VIVADENT AG (LI) | 2019-08-28 | — | — | EP | disclosed |
| EP-1762586-B1 | Method for producing a crosslinked elastomer | SEMPERIT AG HOLDING (AT) | 2012-03-07 | — | — | EP | disclosed |
| EP-1219598-B1 | PHENOLIC COMPOUNDS AND RECORDING MATERIALS CONTAINING THE SAME | NIPPON SODA CO (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20070105971-A1 | METHOD FOR PRODUCING CROSS-LINKED ELASTOMER | SEMPERIT AKTIENGESELLSCHAFT HOLDING (AT) | 2007-05-10 | — | — | US | disclosed |
| EP-1762586-A2 | Method for producing a crosslinked elastomer | Semperit Aktiengesellschaft Holding (AT) | 2007-03-14 | — | — | EP | disclosed |
| CN-1068324-C | Novel pharmaceutical product | LILLY CO ELI (US) | 2001-07-11 | — | — | CN | disclosed |
| CN-1132205-A | Novel pharmaceutical product | LILLY CO ELI (US) | 1996-10-02 | — | — | CN | disclosed |
| US-5491152-A | Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-02-13 | — | — | US | disclosed |
| US-4988662-A | MULTILAYER ELEMENT OF A COATED SUBSTRATE, A FILM WITH A COLOR-FORMING LACTONE, AN ACID AND A SENSITIZER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-01-29 | — | — | US | disclosed |
| US-4988662-A | MULTILAYER ELEMENT OF A COATED SUBSTRATE, A FILM WITH A COLOR-FORMING LACTONE, AN ACID AND A SENSITIZER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-01-29 | — | — | US | disclosed |
| JP-H0229382-A | THERMAL SENSITIVE RECORDING SHEET | DAINIPPON INK & CHEM INC | 1990-01-31 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | CAD, TERB1, MLX | ALDH1A1 1363/4885KMT2A 2159/4885HPGD 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.